about
Plasmapheresis reverses all side-effects of a cisplatin overdose--a case report and treatment recommendationDNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS.Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology ConsortiumRisk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancerRuthenium Complexes Induce HepG2 Human Hepatocellular Carcinoma Cell Apoptosis and Inhibit Cell Migration and Invasion through Regulation of the Nrf2 PathwayA ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin.A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex.Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.Zinc(II) complexes containing bis-benzimidazole derivatives as a new class of apoptosis inducers that trigger DNA damage-mediated p53 phosphorylation in cancer cells.Anticancer activity of silver-N-heterocyclic carbene complexes: caspase-independent induction of apoptosis via mitochondrial apoptosis-inducing factor (AIF).Effect of curcumin on cisplatin- and oxaliplatin-induced oxidative stress in human embryonic kidney (HEK) 293 cells.Hydrogen sulfide ameliorates the kidney dysfunction and damage in cisplatin-induced nephrotoxicity in rat.Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations.Controlled release of liposome-encapsulated temozolomide for brain tumour treatment by convection-enhanced delivery.Bioinformatic analyses revealed underlying biological functions correlated with oxaliplatin responsiveness.Hybrid Nanomaterials Based on Iron Oxide Nanoparticles and Mesoporous Silica Nanoparticles: Overcoming Challenges in Current Cancer Treatments
P2860
Q25257460-8CAF58BD-C231-4F4E-AA33-13B788B2EAEDQ31043552-6D69E9F8-FE28-46E6-B884-C0D527D5893CQ33911016-170C73F1-28B2-48A1-87BD-DB74E14DC4DBQ34477705-983682E1-CCBB-4F74-B752-46979F4C7792Q34648284-E39FE4CC-5E67-47AA-96E6-BF2AFB7BEDA8Q36939364-F7B48D9E-85F6-429E-9FA6-1425985E86FDQ37709331-768BD0E5-8F23-4AE9-AA56-CD4B207C1868Q38956634-28C402DF-E58D-4B4D-81D0-C3BD466D4F24Q39036280-9C98E81A-05CD-4524-A36B-99CBC05828D4Q39103148-04237DDC-7DBE-4EF5-89E3-3583A9610E18Q39184979-1FD65785-5034-4A4F-BCC2-9E1F57FB7531Q39387194-BD5B6B5A-4A6D-476C-BFD7-E863EE7D5B94Q42740245-539D2D3D-4166-43F0-B9A6-C2DF6638355CQ43085121-0C7A983F-2A3B-4F44-898B-F5DEA762C558Q44842257-7526225E-40E3-48A0-B828-BD89448E0F7FQ47984087-EA4C12FB-31C9-4F35-912F-6DD97F653F71Q52927003-F0F56BBE-53EF-4D40-98FB-A14E08E4D344Q59125462-87B68AE5-2F6C-4E3B-A009-3552A7FF4097
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Toxicities of the platinum antineoplastic agents.
@ast
Toxicities of the platinum antineoplastic agents.
@en
type
label
Toxicities of the platinum antineoplastic agents.
@ast
Toxicities of the platinum antineoplastic agents.
@en
prefLabel
Toxicities of the platinum antineoplastic agents.
@ast
Toxicities of the platinum antineoplastic agents.
@en
P2860
P356
P1476
Toxicities of the platinum antineoplastic agents.
@en
P2093
Maurie Markman
P2860
P304
P356
10.1517/14740338.2.6.597
P407
P577
2003-11-01T00:00:00Z